Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 499-504

  Bangaru, Madhavi Latha Yadav ^a   Chen, Shenglin ^a   Woodliff, Jeffrey ^a   Kansra, Sanjay ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Apoptosis; Curcumin; Medulloblastoma

Indexed keywords

CASPASE; CURCUMIN; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MIGRATION INHIBITION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; COLONY-FORMING UNITS ASSAY; CURCUMIN; HUMANS; MEDULLOBLASTOMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; WOUND HEALING;

EID: 77950525326     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pietsch T et al: Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 57: 2085-2088, 1997.
2. Raffel C et al: Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57: 842-845, 1997.
3. Taylor MD et al: Mutations in SUFU predispose to medulloblastoma. Nat Genet 31: 306-310, 2002.
4. Huang H et al: APC mutations in sporadic medulloblastomas. Am J Pathol 156: 433-437 (2000).
5. Yokota N et al: Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101: 198-201, 2002.
6. Hernan R et al: ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res 63: 140-148, 2003.
7. Del VL et al: Insulin-like growth factor I receptor activity in human medulloblastomas. Clin. Cancer Res 8: 1822-1830, 2002.
8. Ozen O et al: Expression of matrix metalloproteinases and their inhibitors in meduUoblastomas and their prognostic relevance. Clin Cancer Res 10: 4746-4753, 2004.
9. McCall TD, Pedone CA and Fults DW: Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice. Cancer Res 67: 5179-5185, 2007.
10. Singh S and Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270: 24995-25000, 1995.
11. Kansra S, Yamagata S, Sneade L, Foster L and Ben Jonaman N: Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release. Mol Cell Endocrinol 239: 27-36, 2005.
12. Klein SB et al: Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways. J Cell Physiol 151: 326-336, 1992.
13. Miller M, Chen S, Woodliff J and Kansra S: Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 149: 4158-4167, 2008.
14. Kansra S, Stoll SW, Johnson JL and Elder JT: Src famUy kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes. Mol Pharmacol 67: 1145-1157, 2005.
15. Jee SH, Shen SC, Tseng CR, Chiu HC and Kuo ML: Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111: 656-661, 1998.
16. Collett GP and Campbell FC: Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25: 2183-2189, 2004.
17. Jiang MC, Yang-Yen HF, Lin JK and Yen JJ: Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 13: 609-616, 1996.
18. Cheng AL et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 27: 2895-2900, 2001.